Myocarditis III: Medical Management
Nephrotic Syndrome III : Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Angina IV: Management
Atherosclerosis III: Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 12, 2025

Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound
Published on: August 4, 2022
Nicholas Lepore1, Taya Carpenter2, Alan Wolff2
1Internal Medicine - Pediatrics, Rutgers New Jersey Medical School, Newark, USA.
Angiotensin-converting enzyme (ACE) inhibitor-induced angioedema risk increases with concurrent use of dipeptidyl peptidase-IV inhibitors and calcium channel blockers. This case highlights the importance of medication review for preventing adverse drug events.
Area of Science:
Background:
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023